Results 201 to 210 of about 144,736 (256)

Persistence and booster response of rabies antibodies among health care workers with multiple vaccinations. [PDF]

Trop Med Health
Castellano MJ, Sornillo JB, Saito N, Nishizono A, Demetria C, Nacion L, Quiambao B.   +6 more
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Durability of COVID-19 vaccine-induced immunity in Saudi Arabia: evidence, gaps, and implications for Hajj and mass-gathering preparedness. [PDF]

Front Public Health
Azhar LE, Alsaieedi AA, AlEissa MM, Baroom HA, Alghoraibi AH, Alzahrani KS, Azhar EI.   +6 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

AI Meets Attitudes: Cross-Sectional Quantitative Study of COVID-19 Vaccine Hesitancy in Alaska's Diverse Communities. [PDF]

J Med Internet Res
Saha PK, Guo J, Khan L, Robinson RF, Haque U.   +4 more
europepmc   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Correction to: Influences on COVID-19 booster uptake among adults intending to receive a booster: a qualitative study. [PDF]

Health Promot Int
europepmc   +1 more source

Unadjuvanted antenatal pertussis OMV vaccination drives enhanced and durable humoral immunity in offspring. [PDF]

Front Immunol
López O, Gaillard ME, Martin Aispuro P, Locati L, Pschunder B, Zurita ME, Escudero C, Bottero D, Hozbor D.   +8 more
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

A second yearly booster dose of the VLA15 Lyme borreliosis vaccine candidate in healthy individuals. [PDF]

Nat Commun
Wagner L, Kadlecek V, Skaroupkova J, Scharnagl N, Hochreiter R, Messier M, Jaramillo JC, Larcher-Steiner J, Hegele L, Lamberth E, Murphy T, Maguire JD, Clarkin C, Derhaschnig U, Eder-Lingelbach S.   +14 more
europepmc   +1 more source